Literature DB >> 12638804

Prevalence of Helicobacter pylori and endoscopic findings in HIV seropositive patients with upper gastrointestinal tract symptoms at Kenyatta National Hospital, Nairobi.

F AliMohamed1, G N Lule, A Nyong'o, J Bwayo, F S Rana.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) seropositive patients frequently experience upper gastrointestinal tract (GIT) symptoms that cause considerable morbidity and are due to multiple aetiologies. The role of Helicobacter pylori gastric mucosal infection in HIV related upper GIT morbidity is unclear. No data exist on the prevalence of H. pylori gastric mucosal infection and upper gastrointestinal endoscopic findings in HIV seropositive patients at the Kenyatta National Hospital.
OBJECTIVES: The aim of the study was to determine the prevalence of H. pylori gastric mucosal infection and the pattern of upper gastrointestinal endoscopic findings in HIV seropositive patients.
DESIGN: A hospital-based prospective case-control study.
SETTING: Kenyatta National Hospital, Endoscopy Unit.
SUBJECTS: Fifty two HIV seropositive patients with upper GIT symptoms were recruited (as well as 52 HIV seronegative age and gender matched controls). INTERVENTION: Both cases and control subjects underwent upper GIT endoscopy and biopsies were taken according to a standard protocol. H. pylori detection was done by the rapid urease test and histology, and H. pylori gastric mucosal infection was considered to be present in the presence of a positive detection by both tests; biopsies were also taken for tissue diagnosis and CD4+ peripheral lymphocyte counts were determined using flow cytometry.
RESULTS: H. pylori prevalence was 73.1% [95% CI 59.9-83.8] in HIV positive subjects and 84.6% [95% CI 72.9-92.6] in HIV negative controls (p=0.230). Prevalence of H. pylori decreased with decreasing peripheral CD4+ lymphocyte counts. Median CD4+ lymphocyte count was 67 cells per cubic millimetre in HIV positive patients. On endoscopy, the most common lesion in HIV positive patients was oesophageal candidiasis (occurring in 51.9%), which was often associated with presence of oral candidiasis and, together with erosions, ulcers and nodules in the oesophagus, occurred exclusively in these patients. A few cases of cytomegalovirus and herpes simplex oesophagitis were seen, as were cases of upper GIT Kaposi's sarcoma, and one gastric lymphoma.
CONCLUSIONS: H. pylori prevalence was not significantly different between HIV positive and HIV negative subjects, and decreased in HIV positive subjects with decreasing CD4+ cell counts. Oesophageal candidiasis was the most important endoscopic finding in HIV positive patients and was often associated with oral thrush.

Entities:  

Mesh:

Year:  2002        PMID: 12638804     DOI: 10.4314/eamj.v79i5.8858

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  10 in total

1.  Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya.

Authors:  Ahmed Kalebi; Farzana Rana; Walter Mwanda; Godfrey Lule; Martin Hale
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

Review 2.  State of the art: gastrointestinal malignancies in the human immunodeficiency virus (HIV) population.

Authors:  Mary Koshy; John Kauh; Clifford Gunthel; Melissa Joyner; Jerome Landry; Charles R Thomas
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Coinfection: Helicobacter pylori/human immunodeficiency virus.

Authors:  Martin Olmos; Valentina Araya; Eduardo Pskorz; Eduardo Coronado Quesada; Hugo Concetti; Hector Perez; Pedro Cahn
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 4.  Prevalence of HIV-associated esophageal candidiasis in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Ronald Olum; Joseph Baruch Baluku; Ronald Okidi; Irene Andia-Biraro; Felix Bongomin
Journal:  Trop Med Health       Date:  2020-09-23

5.  Low prevalence of H. pylori infection in HIV-positive patients in the northeast of Brazil.

Authors:  Andréa B C Fialho; Manuel B Braga-Neto; Eder J C Guerra; André M N Fialho; Karine C Fernandes; Juliana L M Sun; Christianne F V Takeda; Cícero I S Silva; Dulciene M M Queiroz; Lucia L B C Braga
Journal:  BMC Gastroenterol       Date:  2011-02-19       Impact factor: 3.067

6.  HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors.

Authors:  Marcel Nkuize; Stéphane De Wit; Vinciane Muls; Marc Delforge; Véronique Y Miendje Deyi; Guy B Cadière; Michel Buset
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

7.  The increasing prevalence of HIV/Helicobacter pylori co-infection over time, along with the evolution of antiretroviral therapy (ART).

Authors:  Aleksandra Radovanović Spurnić; Branko Brmbolić; Zorica Stojšić; Tatijana Pekmezović; Zoran Bukumirić; Miloš Korać; Dubravka Salemović; Ivana Pešić-Pavlović; Goran Stevanović; Ivana Milošević; Djordje Jevtović
Journal:  PeerJ       Date:  2017-05-30       Impact factor: 2.984

Review 8.  Issues Related to the Treatment of H. pylori Infection in People Living with HIV and Receiving Antiretrovirals.

Authors:  Marcel Nkuize; Stéphane De Wit
Journal:  Microorganisms       Date:  2022-07-29

9.  Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population.

Authors:  Joe Geraghty; Alexander Thumbs; Anstead Kankwatira; Tim Andrews; Andrew Moore; Rose Malamba; Neema Mtunthama; Kai Hellberg; Lughano Kalongolera; Paul O'Toole; Andrea Varro; D Mark Pritchard; Melita Gordon
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  Seroprevalence of helicobacter pylori in human immunodeficiency virus-positive Patients and it's correlation with CD4(+) Lymphocyte Count.

Authors:  Alireza Abdollahi; Saeed Shoar; Siroos Jafari; Hamid Emadi-Kochak
Journal:  Niger Med J       Date:  2014-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.